Russell Investments Group’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42.6K Buy
27,829
+27,308
+5,241% +$41.5K ﹤0.01% 3656
2026
Q1
$943 Buy
521
+21
+4% +$36 ﹤0.01% 4073
2025
Q4
$675 Hold
500
– – ﹤0.01% 4071
2025
Q3
$815 Buy
+500
New +$554 ﹤0.01% 4058
2024
Q4
– Sell
-3,176
Closed -$3.15K – 3764
2024
Q3
$3.15K Buy
+3,176
New +$4.36K ﹤0.01% 3305
2023
Q2
– Sell
-282
Closed -$241 – 3507
2023
Q1
$241 Sell
282
-4,262
-94% -$4.65K ﹤0.01% 3260
2022
Q4
$5.91K Hold
4,544
– – ﹤0.01% 2858
2022
Q3
$8K Sell
4,544
-1,399
-24% -$3.48K ﹤0.01% 2871
2022
Q2
$13K Hold
5,943
– – ﹤0.01% 2835
2022
Q1
$19K Hold
5,943
– – ﹤0.01% 2685
2021
Q4
$27K Sell
5,943
-25,833
-81% -$195K ﹤0.01% 2938
2021
Q3
$228K Buy
+31,776
New +$233K ﹤0.01% 2736

Other funds holding OCGN

Russell Investments Group's OCGN Position: Q2 2026 in Review

Russell Investments Group increased its Ocugen (OCGN) stake by 5,241% in Q2 2026, buying an estimated $41.5K and bringing the position to 27,829 shares worth $42.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3656.

Russell Investments Group first reported a position in OCGN in Q3 2021 and has held it in 12 quarters since. The position peaked at $228K in Q3 2021. 147 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

  • Russell Investments Group held 27,829 shares of Ocugen worth $42.6K as of Q2 2026.
  • Russell Investments Group bought 27,308 Ocugen shares in Q2 2026, an estimated $41.5K.
  • Ocugen made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3656 holding.
  • Russell Investments Group first reported a position in Ocugen in Q3 2021 and has held it in 12 quarters since.
  • Russell Investments Group's Ocugen position peaked at $228K in Q3 2021.
  • 147 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.